April 23, 2026 What the Justice Department did on April 23, 2026 is both progress and a warning. DOJ announced that FDA-approved marijuana products and marijuana products subject to a qualifying state-issued medical license are being placed into Schedule III immediately, while a separate administrative hearing beginning June 29, 2026 will consider the broader question … Continue reading The Bifurcated Rescheduling Confusion: Why Cannabis and Psychedelics Lawyers Must Stay Alert